Trial
NCT02429388
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
—
Condition
Heart Failure
Intervention
Spironolactone
Why stopped
Principal Investigator left institution prior to subjects being enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-04-20